Literature DB >> 6734820

Calmodulin binding to human spectrin.

A Berglund, L Backman, V P Shanbhag.   

Abstract

Calmodulin is shown to interact with human spectrin dimer. The binding was highly calcium-dependent and observed in two different kinds of experiments. Firstly, affinity chromatography of calmodulin on a Sepharose 4B column with immobilized spectrin, and secondly, partition in aqueous two-phase polymer systems. In the column experiments stoichiometric amounts of calmodulin were retained on the spectrin-Sepharose column when micromolar concentrations of calcium were present. The calmodulin bound could be eluted with EGTA. The partition coefficient of calmodulin in an aqueous two-phase polymer system containing calcium was changed upon addition of spectrin, indicating an association between the two proteins. In the absence of calcium, spectrin did not cause any change in the partition behaviour of calmodulin, thus showing that the association requires calcium.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6734820     DOI: 10.1016/0014-5793(84)80884-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Spin label study of erythrocyte deformability. Ca2+-induced loss of deformability and the effects of stomatocytogenic reagents on the deformability loss in human erythrocytes in shear flow.

Authors:  S Noji; S Taniguchi; H Kon
Journal:  Biophys J       Date:  1987-08       Impact factor: 4.033

2.  Spin-labeling studies of the conformation of the Ca(2+)-regulatory protein calmodulin in solution and bound to the membrane skeleton in erythrocyte ghosts: implications to transmembrane signaling.

Authors:  M A Yacko; D A Butterfield
Journal:  Biophys J       Date:  1992-08       Impact factor: 4.033

3.  Modulation of erythrocyte membrane material properties by Ca2+ and calmodulin. Implications for their role in regulation of skeletal protein interactions.

Authors:  Y Takakuwa; N Mohandas
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.